Rupert Vessey Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months, 1 week ago
Rupert Vessey has an estimated net worth of at least $26.6 million*, as of April 9, 2025. They own shares of BMY stock. They have sold 348,545 shares of BMY stock since 2021, for an estimated $24.1 million.
Rupert Vessey $BMY SEC Form 4 Insider Trading
Rupert Vessey has filed a total of 8 insider trades in $BMY since 2021. Their most recent trade was a sale of 50,385 shares, made on May 03, 2023. Their largest trade was a sale of 140,653 shares, made on Jul 30, 2021. We estimate that they now own shares of $BMY, worth an estimated $2.4 million.
Insider Trading at $BMY
There have been a total of 43 insider trades reported at $BMY since 2021, with 23,474 shares purchased and 1.3 million shares sold. The most active insider traders in $BMY stock have been Giovanni Caforio, Rupert Vessey, and Ann Powell. The most recent trade was a sale of 97 shares reported by Benjamin Hickey (President, RayzeBio Org.), made on May 09, 2025.
History of Insider Stock Trades by Rupert Vessey
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 50,385 | May 03, 2023 | May 4, 2023, 5:51 p.m. |
![]() |
Sale | 45,910 | Nov 07, 2022 | Nov. 9, 2022, 9:38 p.m. |
![]() |
Sale | 31,331 | Mar 16, 2022 | March 18, 2022, 5:50 p.m. |
![]() |
Sale | 43,228 | Mar 16, 2022 | March 18, 2022, 5:50 p.m. |
![]() |
Sale | 6,198 | Dec 16, 2021 | Dec. 16, 2021, 8 p.m. |
![]() |
Sale | 13,100 | Dec 16, 2021 | Dec. 16, 2021, 8 p.m. |
![]() |
Sale | 17,740 | Jul 30, 2021 | Aug. 2, 2021, 8 p.m. |
![]() |
Sale | 140,653 | Jul 30, 2021 | Aug. 2, 2021, 8 p.m. |
$BMY Executives and Stock Owners with Insider Trades
-
Giovanni Caforio, Board Chair and CEO
-
Rupert Vessey, EVP, Research & Early Dev.
-
Ann Powell, EVP, Chief Human Resources
-
Autenried Paul Von, EVP, Chief Information Officer
-
David V Elkins, EVP, Chief Financial Officer
-
Christopher S. Boerner, Chief Executive Officer
-
Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev.
-
Sandra Leung, EVP, General Counsel
-
Adam Dubow, SVP,ChiefCompliance&EthicsOff.
-
Benjamin Hickey, President, RayzeBio Org.
-
Christopher S. Boerner, EVP, Chief Commercial Officer
-
Giovanni Caforio, Chairman and CEO
-
Karen Murphy Santiago, SVP & Controller
-
Phil M Holzer, SVP and Controller
-
Rupert Vessey, EVP & President, Research
-
Robert M Plenge, EVP, Chief Research Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.